How does αSyn become pathologically accumulated in PD despite not being upregulated physiologically?

OPEN

The abstract presents a paradox where αSyn accumulates pathologically in PD neurons even though it is not upregulated under physiological conditions. This unexplained observation suggests unknown post-translational or clearance mechanisms that could be therapeutic targets. Gap type: unexplained_observation Source paper: Synuclein and Mitochondrial Dysfunction: Regulating the Protein Import Complex toward PD Treatment? (2026, ACS chemical neuroscience, PMID:41454848)

Priority: 0.82 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How does αSyn become pathologically accumulated in PD despite not being upregulated physiologically? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How does αSyn become pathologically accumulated in PD despite not being upregulated physiologically? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (7)

269BP_ALLELEPD271BP_ALLELEPD265BP_ALLELEPDKEAP1PDBCL2PD
▸ Show 2 more

associated with (13)

PARKINPDTNFPDPINK1PDNLRP3PDNEUROINFLAMMATIONPD
▸ Show 8 more

causes (14)

PDDOPAMINERGIC_NEURONSPDNEURODEGENERATIONLRRK2PDalpha_synucleinPDVPS35PD
▸ Show 9 more

contributes to (1)

PDsynucleinopathies

cross disease mechanism in (6)

SNCAPDMAPTPDTREM2PDNLRP3PDPINK1PD
▸ Show 1 more

describes (1)

therapeutics-adenosine-a2a-receptor-antagonists-pdPD

increases risk (1)

GBA1 mutationsPD

inhibits (1)

267BP_ALLELEPD

interacts with (2)

NRF2PDPDTAU

protects against (2)

NRF2PDKEAP1PD

regulates (1)

TP53PD

treats (1)

EPSPD
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps